NCT06955416: REAMBERIN® 1.5% in Rehydration Therapy of Diabetic Ketoacidosis
- State
- Under way
- Phase
- Phase 2 and Phase 3
- People
- 312 planned
- Started
- 1 May 2025
- Primary completion
- 1 Dec 2027
- Arms
- Reamberin
- Results
- None posted
- 1 May 2025: Trial started
- 2 May 2025: Trial registered